New: NCI-funded clinical trial search
Mednet Logo

For which patients could you consider direct oral amoxicillin challenge as opposed to skin testing for penicillin allergy de-labeling?

Community PollStarted

Are you routinely administering an oral amoxicillin challenge for penicillin allergy de-labeling in patients with low-risk penicillin allergy?

50 physicians have voted

Join Mednetto vote and see how they answered.

2 Answers
Mednet MemberInvited Expert
Infectious Disease · Vanderbilt Asthma Sinus and Allergy Program
Answered on

If a patient can be identified as low-risk by history they should be considered for either historical removal of the label of direct oral challenge. If the history is not compatible with allergy (e.g. they have a family history or have tolerated another drug like Augmentin), historical de-labeling is appropriate. Low-risk patients with a history of penicillin allergy are those with who had non-allergic sounding symptoms (e.g. nausea, headache), did not receive treatment for their previous reaction, had mild to moderate symptoms (e.g. delayed skin rash).

There are scoring tools like the PEN-FAST which can identify those with low-risk penicillin allergy and a randomized open clinical trial that used the PEN-FAST score showed that direct oral ...

Join for free or sign in to see the full answer

Mednet Member
Allergy & Immunology · Allergy And Asthma Associates Inc
Answered on

Helpful tool

Join for free or sign in to see the full answer